Article Details

What Can We Expect From Regulus Therapeutics (NASDAQ:RGLS) After Leerink Swann's Latest ...

Retrieved on: 2018-01-06 00:25:47

Tags for this article:

Click the tags to see associated articles and topics

What Can We Expect From Regulus Therapeutics (NASDAQ:RGLS) After Leerink Swann's Latest .... View article details on hiswai:

Excerpt

<div>Brookstone Cap Mngmt reported 0% in Regulus Therapeutics Inc. (NASDAQ:RGLS). Jpmorgan Chase Com owns 7,606 shares for 0% of their portfolio. <b>Blackrock Inc</b> reported 0% in Regulus Therapeutics Inc. (NASDAQ:RGLS). Northern Trust invested 0% of its portfolio in Regulus Therapeutics Inc.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo